·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆÊ½ºÅ¸Å¬·´TVÆÊµµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ "³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè" ±â»çÀÔ·Â : 04.01.29 21:15:36 0 °¡ ÇÃÄ£Ãß°¡ ¹Ì±¹ ±¹¸³³ëÈ¿¬±¸¼Ò, 549¸í ÃßÀû°á°ú ¹ßº´¿©ºÎ È®¿¬ ³²¼ºÈ£¸£¸ó Å×½ºÅ佺Å×·ÐÀÌ ºÎÁ·ÇÏ¸é ¾ËÃ÷ÇÏÀ̸Ӻ´ À§ÇèÀÌ ³ô¾ÆÁø´Ù´Â ¿¬±¸°á°ú°¡ ³ª¿Ô´Ù. ¹Ì±¹ ±¹¸³³ëÈ¿¬±¸¼Ò(NIA) ¼öÀü ·¹½º´Ð ¹Ú»ç´Â '½Å°æÀÇÇÐ' ÃÖ½ÅÈ£¿¡ ¹ßÇ¥ÇÑ º¸°í¼¿¡¼ À̰°ÀÌ ÁÖÀåÇß´Ù. ¼öÀü ¹Ú»ç´Â ³²ÀÚ 549¸í¸¦ 19³âµ¿¾È ÃßÀûÇÏ¸é¼ Áß°£Áß°£ Ç÷Áß Å×½ºÆ®·Î½ºÅ×·Ð ¼öÄ¡¸¦ °Ë»çÇÏ°í ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´¿©ºÎ¸¦ Á¶»çÇß´Ù. ÀÌ ¿¬±¸¿¡¼ 54¸íÀÌ ¾ËÃ÷ÇÏÀ̸Ӻ´¿¡ °É·Á ´Ù¸¥ ´Ü¹éÁúµé°ú °áÇÕÇÏ°í ³²Àº À¯¸®Çü(free) Å×½ºÅ佺Å×·ÐÀÇ Ç÷Áß ¼öÄ¡°¡ ³·À»¼ö·Ï ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´·üÀÌ ³ô°í ¼öÄ¡°¡ ³ôÀ»¼ö·Ï ¹ßº´·üÀÌ ³·¾Ò´Ù°í ¸»Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ Á¤½Ã¿í ±âÀÚ(sujung@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ "³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè" ±â»çÀÔ·Â : 04.01.29 21:15:36 0 °¡ ÇÃÄ£Ãß°¡ ¹Ì±¹ ±¹¸³³ëÈ¿¬±¸¼Ò, 549¸í ÃßÀû°á°ú ¹ßº´¿©ºÎ È®¿¬ ³²¼ºÈ£¸£¸ó Å×½ºÅ佺Å×·ÐÀÌ ºÎÁ·ÇÏ¸é ¾ËÃ÷ÇÏÀ̸Ӻ´ À§ÇèÀÌ ³ô¾ÆÁø´Ù´Â ¿¬±¸°á°ú°¡ ³ª¿Ô´Ù. ¹Ì±¹ ±¹¸³³ëÈ¿¬±¸¼Ò(NIA) ¼öÀü ·¹½º´Ð ¹Ú»ç´Â '½Å°æÀÇÇÐ' ÃÖ½ÅÈ£¿¡ ¹ßÇ¥ÇÑ º¸°í¼¿¡¼ À̰°ÀÌ ÁÖÀåÇß´Ù. ¼öÀü ¹Ú»ç´Â ³²ÀÚ 549¸í¸¦ 19³âµ¿¾È ÃßÀûÇÏ¸é¼ Áß°£Áß°£ Ç÷Áß Å×½ºÆ®·Î½ºÅ×·Ð ¼öÄ¡¸¦ °Ë»çÇÏ°í ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´¿©ºÎ¸¦ Á¶»çÇß´Ù. ÀÌ ¿¬±¸¿¡¼ 54¸íÀÌ ¾ËÃ÷ÇÏÀ̸Ӻ´¿¡ °É·Á ´Ù¸¥ ´Ü¹éÁúµé°ú °áÇÕÇÏ°í ³²Àº À¯¸®Çü(free) Å×½ºÅ佺Å×·ÐÀÇ Ç÷Áß ¼öÄ¡°¡ ³·À»¼ö·Ï ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´·üÀÌ ³ô°í ¼öÄ¡°¡ ³ôÀ»¼ö·Ï ¹ßº´·üÀÌ ³·¾Ò´Ù°í ¸»Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ Á¤½Ã¿í ±âÀÚ(sujung@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç 2025³â »ó¹Ý±â ¼ö½Ãä¿ë(ÇмúÀÇÇнÇ, BDÆÀ ¾à»ç) ¹Ù·Î°¡±â º»»ç Medical Affairs ä¿ë ¹Ù·Î°¡±â º»»ç ½ÅÀÔ RA ¾à»ç ä¿ë ¹Ù·Î°¡±â RA, PMS, MSL ,PM, MR, MM µî °¢ ºÎ¹® ¸ðÁý ¹Ù·Î°¡±â [Çѵ¶] Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®, MA, Ãѹ« ÆÀÀå, Á¦Á¶°ü¸® ¾à»ç, ÀÌÈÇнÃÇè(QC), ±â¼úÆÀ ±³Á¤´ã´ç, Àü¹®ÀǾàǰ ¸¶ÄÉÆÃ, ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ ¹Ù·Î°¡±â ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â R&D¼¾ÅÍ ¿¬±¸¿ø ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â Sr. RA Specialist & RA Specialist (2 Year Contract) ¹Ù·Î°¡±â °¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ "³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè" ±â»çÀÔ·Â : 04.01.29 21:15:36 0 °¡ ÇÃÄ£Ãß°¡ ¹Ì±¹ ±¹¸³³ëÈ¿¬±¸¼Ò, 549¸í ÃßÀû°á°ú ¹ßº´¿©ºÎ È®¿¬ ³²¼ºÈ£¸£¸ó Å×½ºÅ佺Å×·ÐÀÌ ºÎÁ·ÇÏ¸é ¾ËÃ÷ÇÏÀ̸Ӻ´ À§ÇèÀÌ ³ô¾ÆÁø´Ù´Â ¿¬±¸°á°ú°¡ ³ª¿Ô´Ù. ¹Ì±¹ ±¹¸³³ëÈ¿¬±¸¼Ò(NIA) ¼öÀü ·¹½º´Ð ¹Ú»ç´Â '½Å°æÀÇÇÐ' ÃÖ½ÅÈ£¿¡ ¹ßÇ¥ÇÑ º¸°í¼¿¡¼ À̰°ÀÌ ÁÖÀåÇß´Ù. ¼öÀü ¹Ú»ç´Â ³²ÀÚ 549¸í¸¦ 19³âµ¿¾È ÃßÀûÇÏ¸é¼ Áß°£Áß°£ Ç÷Áß Å×½ºÆ®·Î½ºÅ×·Ð ¼öÄ¡¸¦ °Ë»çÇÏ°í ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´¿©ºÎ¸¦ Á¶»çÇß´Ù. ÀÌ ¿¬±¸¿¡¼ 54¸íÀÌ ¾ËÃ÷ÇÏÀ̸Ӻ´¿¡ °É·Á ´Ù¸¥ ´Ü¹éÁúµé°ú °áÇÕÇÏ°í ³²Àº À¯¸®Çü(free) Å×½ºÅ佺Å×·ÐÀÇ Ç÷Áß ¼öÄ¡°¡ ³·À»¼ö·Ï ¾ËÃ÷ÇÏÀ̸Ӻ´ ¹ßº´·üÀÌ ³ô°í ¼öÄ¡°¡ ³ôÀ»¼ö·Ï ¹ßº´·üÀÌ ³·¾Ò´Ù°í ¸»Çß´Ù. X AD 2025 µÑÄÚ¶ô½º ½ÉÆ÷Áö¾ö REPLAY À̺¥Æ®Âü¿© ¡æ Á¤½Ã¿í ±âÀÚ(sujung@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æÄ§ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ³²¼ºÈ£¸£¸ó ºÎÁ·ÇÏ¸é ¾ËÂêÇÏÀÌ¸Ó À§Çè URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ īī¿À½ºÅ丮 īī¿ÀÅå ¹êµå ³×À̹ö